Bank Of New York Mellon Corp Monte Rosa Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$6.71 - $9.72 $599,149 - $867,918	89,292 New	89,292 $679,000
Q3 2022 Nov 14, 2022	BUY	$7.17 - $12.16 $124,930 - $211,875	17,424 Added 24.82%	87,632 $716,000
Q2 2022 Aug 15, 2022	SELL	$6.15 - $14.99 $25,282 - $61,623	-4,111 Reduced 5.53%	70,208 $679,000
Q1 2022 May 11, 2022	BUY	$10.36 - $20.41 $438,642 - $864,159	42,340 Added 132.4%	74,319 $1.04 Million
Q4 2021 Feb 11, 2022	BUY	$16.28 - $27.15 $67,122 - $111,939	4,123 Added 14.8%	31,979 $653,000
Q3 2021 Nov 12, 2021	BUY	$18.59 - $42.21 $517,843 - $1.18 Million	27,856 New	27,856 $621,000

43.9M

141K

31.2K

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $426M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.